Dubai - Sharikat Mubasher: Nabta Health, a UAE-based healthcare company, successfully closed a $2 million pre-Series A round, bringing its total funding to date to $4.5 million.
This investment will allow Nabta to deepen partnerships with employers, insurers, and healthcare providers, introduce new diagnostic and at-home testing pathways, and strengthen its clinical infrastructure in collaboration with leading hospitals, the company announced in a press release today.
The funding marks a significant milestone in Nabta’s mission to deliver accessible, evidence-based women’s healthcare and to expand its AI-powered hybrid model across the Middle East and Africa.
Sophie Smith, Founder and CEO of Nabta Health, affirmed that the round validates the company's vision of reimagining women’s health through an AI-powered, hybrid care model that meets women where they are, respects cultural context, and delivers measurable outcomes.
“We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty,” she added.
Meanwhile, Iain McMillan, Chair at Nabta Health, commented: “The closing of this pre-Series A round is confirmation that Nabta Health is being increasingly recognized in the region as a key enabler of measurably better women’s health. The business has steadily gained traction and grown its customer base throughout 2025, and I am looking forward to seeing further acceleration in our success as we move forward into 2026 and beyond.”
This year, Nabta launched the Women’s Health Centre of Excellence in partnership with Clemenceau Medical Center Hospital in Dubai and expanded its corporate health solutions across the region.
